You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 4, April 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Amelioration of light-induced retinal degeneration by a calcium overload blocker. Flunarizine

D. P. Edward, T. T. Lam, S. Shahinfar, J. Li and M. O. Tso
Georgiana Dvorak Theobald Ophthalmic Pathology Laboratory, Department of Ophthalmology, University of Illinois, Chicago College of Medicine 60612.

Although free radical formation and lipid peroxidation have been implicated in photoreceptor degeneration following continuous light exposure, recent evidence led us to hypothesize that excessive stimulation of the photoreceptor cells in prolonged light exposure may cause intracellular calcium overload and consequent photoreceptor cell injury. To test this hypothesis, we studied the effects of flunarizine hydrochloride, a calcium overload blocker that inhibits the inositol 1,4,5-triphosphate-induced release of intracellular stores of calcium, in an established rat model of light-induced retinal degeneration. Light and electron microscopic examination of the flunarizine-treated retinas revealed remarkable preservation of the retinal pigment epithelium, rod inner and outer segments, nuclei, and synapses of the photoreceptor cells at all phases of the recovery period. This observation was further supported by morphometric evaluation of the outer nuclear layer thickness, which revealed a greater preservation of the photoreceptor nuclei in the drug-treated animals at 6 and 14 days after exposure. In addition, the rhodopsin levels in the flunarizine-treated retinas were also significantly higher than in the controls in all phases of recovery. The ability of flunarizine to ameliorate light-induced retinal degeneration in the rat supports our hypothesis that elevated intracellular calcium may indeed play a role in light-induced photoreceptor degeneration.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Calcium-induced Calpain Mediates Apoptosis via Caspase-3 in a Mouse Photoreceptor Cell Line
Sharma and Rohrer
J. Biol. Chem. 2004;279:35564-35572.
ABSTRACT | FULL TEXT  

Effects of melatonin on the nitric oxide treated retina
Siu et al.
Br. J. Ophthalmol. 2004;88:1078-1081.
ABSTRACT | FULL TEXT  

NF-{kappa}B Activation in Light-Induced Retinal Degeneration in a Mouse Model
Wu et al.
IOVS 2002;43:2834-2840.
ABSTRACT | FULL TEXT  

Topical Flunarizine Reduces IOP and Protects the Retina against Ischemia-Excitotoxicity
Osborne et al.
IOVS 2002;43:1456-1464.
ABSTRACT | FULL TEXT  

In Vivo Protection of Photoreceptors from Light Damage by Pigment Epithelium-Derived Factor
Cao et al.
IOVS 2001;42:1646-1652.
ABSTRACT | FULL TEXT  

Circadian-Dependent Retinal Light Damage in Rats
Organisciak et al.
IOVS 2000;41:3694-3701.
ABSTRACT | FULL TEXT  

Metals and Disorders of Cell Accumulation: Modulation of Apoptosis and Cell Proliferation
Waalkes et al.
Toxicol Sci 2000;56:255-261.
FULL TEXT  

Lead and Calcium Produce Rod Photoreceptor Cell Apoptosis by Opening the Mitochondrial Permeability Transition Pore
He et al.
J. Biol. Chem. 2000;275:12175-12184.
ABSTRACT | FULL TEXT  

Calcium Overload Triggers Rod Photoreceptor Apoptotic Cell Death in Chemical-Induced and Inherited Retinal Degenerations
FOX et al.
Ann. N. Y. Acad. Sci. 1999;893:282-285.
FULL TEXT  

Light-induced Photoreceptor Apoptosis in Vivo Requires Neuronal Nitric-oxide Synthase and Guanylate Cyclase Activity and Is Caspase-3-independent
Donovan et al.
J. Biol. Chem. 2001;276:23000-23008.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.